BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7950170)

  • 21. Chronic anemia after lung transplantation: treatment with human recombinant erythropoietin.
    End A; Ringl H; Grimm M; Schlick W; Schreiner W; Klepetko W; Wolner E
    Transplantation; 1994 Apr; 57(7):1142. PubMed ID: 8165717
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of preoperative treatment with recombinant human erythropoietin in patients undergoing hemodilutional autologous transfusion].
    Nakae Y; Sonoda H; Miyabe M; Kawamata M; Sakakibara N; Kawana S; Namiki A
    Masui; 1995 Oct; 44(10):1362-8. PubMed ID: 8538004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Autologous blood donation with recombinant human erythropoietin prior to elective cardiac surgery in anemic patients].
    Kiyama H; Ohshima N; Imazeki T; Yamada T
    Kyobu Geka; 1998 Aug; 51(9):741-4. PubMed ID: 9742815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recombinant human erythropoietin in the treatment of the anemia of gynecological tumor patients].
    Kurata H; Yoshiya N; Higashino M; Igarashi H; Kaneko T; Kodama S; Tanaka K
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2243-5. PubMed ID: 8239694
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
    Henry DH; Abels RI
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phase II clinical study of recombinant human erythropoietin on the anemia associated with multiple myeloma].
    Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
    Rinsho Ketsueki; 1993 Aug; 34(8):919-27. PubMed ID: 8411646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phase II clinical study of recombinant human erythropoietin on the anemia of myelodysplastic syndrome].
    Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
    Rinsho Ketsueki; 1993 Aug; 34(8):928-36. PubMed ID: 8411647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of recombinant erythropoietin during the preoperative period].
    Janssens M; Lamy M
    Ann Fr Anesth Reanim; 1995; 14 Suppl 1():98-106. PubMed ID: 7486323
    [No Abstract]   [Full Text] [Related]  

  • 29. Erythropoietin treatment of erythropoietin-deficient anemia without renal disease during pregnancy.
    Harris SA; Payne G; Putman JM
    Obstet Gynecol; 1996 May; 87(5 Pt 2):812-4. PubMed ID: 8677097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Erythropoietin treatment: concept and controversy].
    Sans Mateu T
    Sangre (Barc); 1998 Aug; 43(4):327-30. PubMed ID: 9790000
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
    Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
    Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical application of recombinant erythropoietin in the perioperative period.
    Goodnough LT
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):1011-20. PubMed ID: 7852209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human erythropoietin at high dose is effective for the treatment of the anemia of myelodysplastic syndromes.
    Laporte JP; Isnard F; Fenaux P; Woler M; Najman A
    Contrib Nephrol; 1991; 88():271-2; discussion 273-5. PubMed ID: 2040189
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of anemia and stimulation of hematopoiesis in patients submitted to heart surgery with extracorporeal circulation].
    Shevchenko IuL; Solov'eva NIu
    Vestn Khir Im I I Grek; 1998; 157(2):97-100. PubMed ID: 9691396
    [No Abstract]   [Full Text] [Related]  

  • 35. Does anemia correction by rHuEPO improve uremic cardiopathy?
    Carletti P; Bibiano L; Boggi R; Taruscia D; Mioli V
    Kidney Int Suppl; 1993 Jun; 41():S70-1. PubMed ID: 8320949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of erythropoietin in anemia after heart transplantation.
    Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ
    Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human erythropoietin for long-term treatment of anemia in paroxysmal nocturnal hemoglobinuria.
    Balleari E; Gatti AM; Mareni C; Massa G; Marmont AM; Ghio R
    Haematologica; 1996; 81(2):143-7. PubMed ID: 8641643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythropoietin's role in transfusion medicine: the view from a blood bank.
    Menitove JE
    Oncology (Williston Park); 1991 Jun; 5(6):60, 65, 68. PubMed ID: 1831641
    [No Abstract]   [Full Text] [Related]  

  • 39. Erythropoietin in cardiac surgery.
    Helm RE; Gold JP; Rosengart TK; Zelano JA; Isom OW; Krieger KH
    J Card Surg; 1993 Sep; 8(5):579-606. PubMed ID: 8219540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stable renal function and benign course in azotemic diabetics treated with erythropoietin for one year.
    Brown CD; Friedman EA
    Contrib Nephrol; 1991; 88():182-9; discussion 190-1. PubMed ID: 2040181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.